LEKLI sh.p.k donates 526,750 (UI) Human Coagulation Factor VIII 250 UI/ 500 UI to the University Hospital Center “Mother Teresa”, in Tirana, to cover the needs of its patients.
“This is the second donation by LEKLI sh.p.k in this past year, following the donation of Hydroxychloroquine Sulfate 200 mg to the COVID-19 Department of Infectious Diseases”, stated the Head of Finance, Mrs. Enxhi Konini.
The collaboration with the MoH and the UHC “Mother Teresa” will continue in the future.
ABOUT LEKLI SH.P.K
LEKLI sh.p.k is a pharmaceutical company focused on market research and manufacture of medical products for human use.Our experience in pharmaceuticals began in 1986 and resulted in the establishment of LEKLI sh.p.k in 1991 by Dr. Luan Lekli. During these years, LEKLI sh.p.k managed to grow from a well- established Pharma company to a company with cross border presence.
In the following years, we specialized in the field of rare diseases, leading the market and making sure that every single patient is able to live a better life. In 2015, LEKLI sh.p.k established a production facility, manufacturing generic drugs, Phytotherapeutics and orphan drugs. To cover all the needs of the Albanian market, we produce prescription, non-prescription, extemporaneous and stock pharmaceutical preparations.
Our experience spans more than 25 years in the Balkan market, during which we have established our presence through our operations in Albania and in Kosovo.
Today we have a strong brand equity and awareness. Together with our highly motivated, experienced and empowered management team we lead the market in special indications areas.
For more information: www.leklipharma.com/al/